These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2600545)
1. Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. Albers JJ; Lodge MS; Curtiss LK J Lipid Res; 1989 Sep; 30(9):1445-58. PubMed ID: 2600545 [TBL] [Abstract][Full Text] [Related]
2. Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Young SG; Smith RS; Hogle DM; Curtiss LK; Witztum JL Clin Chem; 1986 Aug; 32(8):1484-90. PubMed ID: 3524903 [TBL] [Abstract][Full Text] [Related]
3. Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. Weisgraber KH; Innerarity TL; Newhouse YM; Young SG; Arnold KS; Krauss RM; Vega GL; Grundy SM; Mahley RW Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9758-62. PubMed ID: 3200853 [TBL] [Abstract][Full Text] [Related]
4. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins. Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944 [TBL] [Abstract][Full Text] [Related]
5. Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47. Young SG; Koduri RK; Austin RK; Bonnet DJ; Smith RS; Curtiss LK J Lipid Res; 1994 Mar; 35(3):399-407. PubMed ID: 7516960 [TBL] [Abstract][Full Text] [Related]
6. Dissociation of LPL and LDL: effects of lipoproteins and anti-apoB antibodies. Choi SY; Pang L; Kern PA; Kayden HJ; Curtiss LK; Vanni-Reyes TM; Goldberg IJ J Lipid Res; 1997 Jan; 38(1):77-85. PubMed ID: 9034202 [TBL] [Abstract][Full Text] [Related]
7. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998 [TBL] [Abstract][Full Text] [Related]
8. Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins. Gaw A; Packard CJ; Lindsay GM; Griffin BA; Caslake MJ; Lorimer AR; Shepherd J J Lipid Res; 1995 Jan; 36(1):158-71. PubMed ID: 7706941 [TBL] [Abstract][Full Text] [Related]
9. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy. Aguilar-Salinas CA; Hugh P; Barrett R; Pulai J; Zhu XL; Schonfeld G Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):72-82. PubMed ID: 9012640 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein B (apoB) concentrations in lipoproteins in cows. Uchide T; Tohya Y; Onda K; Matsuki N; Inaba M; Ono K J Vet Med Sci; 1997 Aug; 59(8):711-4. PubMed ID: 9300370 [TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay for human plasma apolipoprotein B. Ordovas JM; Peterson JP; Santaniello P; Cohn JS; Wilson PW; Schaefer EJ J Lipid Res; 1987 Oct; 28(10):1216-24. PubMed ID: 3681146 [TBL] [Abstract][Full Text] [Related]
12. A selective bi-site immunoenzymatic procedure for human Lp[a] lipoprotein quantification using monoclonal antibodies against apo[a] and apoB. Vu Dac N; Mezdour H; Parra HJ; Luc G; Luyeye I; Fruchart JC J Lipid Res; 1989 Sep; 30(9):1437-43. PubMed ID: 2532239 [TBL] [Abstract][Full Text] [Related]
13. Conservation of the low density lipoprotein receptor-binding domain of apoprotein B. Demonstration by a new monoclonal antibody, MB47. Young SG; Witztum JL; Casal DC; Curtiss LK; Bernstein S Arteriosclerosis; 1986; 6(2):178-88. PubMed ID: 3954672 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein[a] is not associated with apolipoprotein B in human liver. Wilkinson J; Munro LH; Higgins JA J Lipid Res; 1994 Oct; 35(10):1896-901. PubMed ID: 7852867 [TBL] [Abstract][Full Text] [Related]
15. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235 [TBL] [Abstract][Full Text] [Related]
16. Determination of apolipoprotein B-48 in plasma by a competitive ELISA. Lorec AM; Juhel C; Pafumi Y; Portugal H; Pauli AM; Lairon D; Defoort C Clin Chem; 2000 Oct; 46(10):1638-42. PubMed ID: 11017943 [TBL] [Abstract][Full Text] [Related]
17. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach. Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585 [TBL] [Abstract][Full Text] [Related]
18. Semi-automated enzyme-linked immunosorbent assay (ELISA) for the quantification of apolipoprotein B using monoclonal antibodies. Bojanovski M; Gregg RE; Wilson DM; Brewer HB Clin Chim Acta; 1987 Dec; 170(2-3):271-80. PubMed ID: 3436061 [TBL] [Abstract][Full Text] [Related]
19. Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblasts is mediated by apolipoprotein E. Linga V; Leight MA; Curtiss LK; Marcel YL; St Clair RW; Parks JS J Lipid Res; 1994 Mar; 35(3):491-500. PubMed ID: 8014584 [TBL] [Abstract][Full Text] [Related]
20. Effect of lipid transfer activity and triglyceride hydrolysis on apolipoprotein B immunoreactivity in modified low density lipoproteins. Viens L; Lagrost L J Lipid Res; 1997 Jun; 38(6):1129-38. PubMed ID: 9215541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]